Você procurou por: hypophosphatemia (Inglês - Maltês)

hypophosphatemia
ipofosfatemja

anorexia hyperglycaemia hypocalcaemia hypokalaemia hypomagnesaemia hypophosphatemia
anoreksja ipergliċemija ipokalċemija ipokalemija ipomagnesemija ipofosfatemija

renal failure, abnormal renal function, hypophosphatemia
kollass tal-kliewi, funzjoni renali anormali, ipofosfatimja

hyponatremia, alkalosis, hypophosphatemia, tumour lysis syndrome, hypocalcaemiad
iponatremija, alkalożi, ipofosfatemija, sindrome tal-lisi tat-tumur, ipokalċemijad

therefore, patients with a risk for hypophosphatemia should be closely followed.
għalhekk, il-pazjenti b’riskju għal ipofosfatemija għandhom jiġu sorveljati mill- qrib.

hypophosphatemia and a decrease in carnitine concentrations were reported each in 3 % of patients on extended treatment.
ipofosfatemja u tnaqqis fil-konċentrazzjonijiet tal-carnitine kienu t-tnejn irrappurtati fi 3% tal-pazjenti li kienu fuq trattament imtawwal.

hypophosphatemia as with other nicotinic acid medicinal products, pelzont was associated with small decreases in phosphorus levels.
4 ipofosfatemja bħal fi prodotti mediċinali ta ’ l- aċidu nikotiniku oħrajn, pelzont kien assoċjat ma ’ tnaqqis żgħir fil - livelli ta ’ fosfru.

common (≥ 1/ 100, < 1/ 10): renal failure, abnormal renal function, hypophosphatemia.
komuni (≥ 1/ 100, < 1/ 10): kollass tal- kliewi, funzjoni renali anormali, ipofosfatimja.

grade 3 and 4 hypocalcemia and hypophosphatemia were reported in patients with all phases of cml but were reported with an increased frequency in patients with myeloid or lymphoid blast phase cml and ph+ all.
ipokalċimja u ipofosfatimja ta ’ grad 3 u 4 ġew irrapportati f’ pazjenti bil- fażijiet kollha ta ’ cml imma kienu rrapportati bi frekwenza akbar f’ pazjenti b’ cml splussiva tal- majelojd jew tal- limfojde u ph+all.

in patients with hereditary fructose intolerance, parenteral administration of sorbitol has been associated with reports of hypoglycemia, hypophosphatemia, metabolic acidosis, increase in uric acid, acute liver failure with breakdown of excretory and synthetic function, and death.
f'pazjenti b'intolleranza ereditarja għall-fruttożju, l-għoti parenterali ta' sorbitol ġie assoċjat ma' rapporti ta' ipogliċemija, ipofosfatemija, aċidożi metabolika, żieda fl-aċidu uriku, indeboliment akut tal-fwied bi tkissir tal-funzjoni ta' eskrezzjoni u sintetika, u mewt.